May Hayat was seconds from being killed in a ‘death trap ambulance’ (Picture: Kevin Moran / Luke Alsford / Metro)
READ MORESome 27 people have died and dozens more are injured after a fire in a Bangkok on Sunday. Police todya confirmed they were looking into whether had blocked emergency exits,preventing some people from
Ray is believed to have died mere days after his 88th birthday, which he celebrated at the Big Ben pub
JAKARTA,Indonesia,Jan. 6,2025-- The Indonesian version of theaudiobook Namun Tetap Ada Rasa was successfully launched in Indonesia,quickly garnering enthusiastic responses from local readers and liste
First-ever collaboration introduces a robust perception stack for automated driving STRADVISION\'s 3D Perception SVNet enables deep learning-based embedded perception algorithms using AMD Versal™ AI
GUANGZHOU,China,Jan. 6,2025-- At the dawn of a new year,the renowned fashion brand URBAN REVIVO (UR) proudly celebrates significant milestones in its international market expansion throughout 2024 and
PANJIT\'s ultra-low capacitance ESD protection devices earned significant recognition among engineers.
LAS VEGAS and SEOUL,South Korea,Jan. 6,2025-- Seomjae,a rising EdTech startup from Korea,set to make a splash atCES 2025 with its brand-new AI learning platform,CHALK. The company first unveiled CHALK
XUZHOU,China,Jan. 6,2025-- On January 3,the company took proactive measures to guarantee that residents in both urban and rural areas stay warm during the winter. Staff members conducted thorough insp
- Immersive XR Technology Combines Scent,Touch,and Media Art to Revolutionize Customer Engagement SEOUL,South Korea,Jan. 6,2025-- Sharebox Co.,Ltd. is setting new standards in the commercial and publi
BEIJING,Jan. 6,2025-- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM),a healthcare provider specialized in cancer treatment,research,educ
CHENGDU,China,Jan. 6,2025-- Technoderma Medicines,Inc. ("the Company"),a clinical stage biopharmaceutical company,is pleased to report the Company has completed its Phase 2a clinical trial (
The New Agreements Projected to Generate Sales of up to 140,000 Units and $11 Million in Revenue by Year End 2025
© OfficialAffairs
